Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
This study is a pilot, ascending dose, multi-center, randomized, double blind, placebo controlled, pediatric study conducted in three phases.
Epistemonikos ID: df55df71b8a528937faf46715ec9718617f05ef2
First added on: May 11, 2024